Introduction to Clinical Variant Interpretation: EOI

Introduction to Clinical Variant Interpretation: EOI

Three in-person workshops (Wednesday 31 Jan, Thursday 22 Feb, Tuesday 26 Mar 2024), each preceded by interactive online pre-reading periods.

By Melbourne Genomics Health Alliance

Location

The Royal Children's Hospital, Melbourne

50 Flemington Road Vernon Collins Theatre 1.050-HELP-1st floor West Parkville, VIC 3052 Australia

About this event

This course is designed for medical scientists who intend to move (or have recently moved) into diagnostic genomic testing for rare germline disorders. It is also relevant to clinicians and researchers involved in this field.

Attendees will gain an appreciation of the principles of variant interpretation relevant to medical scientists specialising in germline genomic testing. They will also have the opportunity to use common variant interpretation tools, software and databases in a learning environment and work through real-world cases with expert guidance.


LEARNING OUTCOMES

  • Explain the processes and limitations of variant interpretation in routine clinical care
  • Describe how a clinical context is integrated into the variant interpretation process
  • Collect evidence from variant databases, in silico tools, and scientific literature to curate variants
  • Use evidence to classify variants based on current clinical standards and guidelines
  • Describe how the process of variant interpretation is integral to the generation of genomic test reports


INSTRUCTORS INCLUDE

  • Bryony Thompson, Senior Genomics Scientist, Royal Melbourne Hospital
  • Corrina Cliffe, Supervising Scientist, Genomics at NSW Health Pathology
  • Lyndon Gallacher, Genetic Counsellor FHGSA, Victorian Clinical Genetics Services
  • Victoria Beshay, Senior Scientist, Victorian Comprehensive Cancer Centre Alliance


COURSE STRUCTURE

The course is comprised of three in-person all-day workshops which are recommended to be taken in sequence but can be stand-alone.

Each workshop will be held on-site in teaching spaces at the Royal Children’s Hospital, according to COVID-safe guidelines.

Each workshop is preceded by a pre-reading period. Registrants will be expected to have reviewed relevant online modules prior to the workshop.


ONLINE PREREADING: Opens Tuesday 2 January 2024, ~25h total estimated read time across three months.


WORKSHOP 1: Foundations of variant interpretation

Date: Wednesday 31 January 2024

  • Foundational genetic concepts
  • Introduction to clinical bioinformatics
  • Introduction to variant interpretation and curation
  • Variant prioritisation and filtering


WORKSHOP 2: Variant curation

Date: Thursday 22 February 2024

  • Using online curation tools
  • Analysing the effect of variants on protein function
  • Analysing the scientific literature and co-segregation
  • Case study


WORKSHOP 3: Variant classification and genomic test reporting

Date: Tuesday 26 March 2024

  • Variant classification
  • Genomic test reporting
  • Case study


Please note, this is an expression of interest only. You will be advised by email if your registration is confirmed.


If you have any further queries, please contact the Melbourne Genomics Workforce team at education@melbournegenomics.org.au.

Organised by

Genomics has huge potential to improve healthcare. Looking at the genome can help diagnose illness more quickly and easily, as well as help understand what treatment or care might be most effective.

Melbourne Genomics is an alliance of 10 leading healthcare and research organisations dedicated to bringing the global knowledge of genomics to benefit the individual care of Victorians.

Together, The Royal Melbourne Hospital, The Royal Children’s Hospital, The University of Melbourne, The Walter and Eliza Hall Institute, the Murdoch Children's Research Institute, the CSIRO, the Australian Genome Research Facility, the Peter MacCallum Cancer Centre, Austin Health and Monash Health are forging a path forward for patients, clinicians and researchers to benefit from the enormous potential of genomics.

Sales Ended